Ion channels and the hallmarks of cancer

Trends in Molecular Medicine

Volumn 16, Issue 3, 2010, Pages 107-121

  Prevarskaya, Natalia ^a   Skryma, Roman ^a   Shuba, Yaroslav ^b  

^a Université des Sciences et Technologies de Lille   (France)

^b BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

ION CHANNEL;

ANGIOGENESIS; APOPTOSIS; CANCER INVASION; CELL DIVISION; CELL GROWTH; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; HUMANS; ION CHANNELS; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 77949327468     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2010.01.005     Document Type: Review

References (149)

1. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
2. Fraser S.P., and Pardo L.A. Ion channels: functional expression and therapeutic potential in cancer. Colloquium on Ion Channels and Cancer. EMBO Rep. 9 (2008) 512-515
3. + channels: role in apoptosis and tumorigenesis. Pflugers Arch. 448 (2004) 261-273
4. Pardo L.A., et al. Role of voltage-gated potassium channels in cancer. J. Membr. Biol. 205 (2005) 115-124
5. Kunzelmann K. Ion channels and cancer. J. Membr. Biol. 205 (2005) 159-173
6. Roger S., et al. Voltage-gated sodium channels: new targets in cancer therapy?. Curr. Pharm. Des. 12 (2006) 3681-3695
7. Camacho J. Ether à go-go potassium channels and cancer. Cancer Lett. 233 (2006) 1-9
8. Panner A., and Wurster R.D. T-type calcium channels and tumor proliferation. Cell Calcium 40 (2006) 253-259
9. Fiske J.L., et al. Voltage-sensitive ion channels and cancer. Cancer Metastasis Rev. 25 (2006) 493-500
10. Prevarskaya N., et al. TRP channels in cancer. Biochim. Biophys. Acta 1772 (2007) 937-946
11. + channels in cellular migration: regulation of central nervous system development and potentiation of invasive cancers. Neuroscientist 14 (2008) 571-583
12. Onganer P.U., et al. Neuronal characteristics of small-cell lung cancer. Br. J. Cancer 93 (2005) 1197-1201
13. McFerrin M.B., and Sontheimer H. A role for ion channels in glioma cell invasion. Neuron Glia Biol. 2 (2006) 39-49
14. Prevarskaya N., et al. Ion channels in death and differentiation of prostate cancer cells. Cell Death Differ. 14 (2007) 1295-1304
15. + channel expression in human breast cancer cells: involvement in cell cycle regulation and carcinogenesis. J. Membr. Biol. 221 (2008) 1-6
16. Arcangeli A., et al. Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr. Med. Chem. 16 (2009) 66-93
17. Grabowski P., et al. Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer. Eur. J. Gastroenterol. Hepatol. 13 (2001) 405-411
18. Howe M.C., et al. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy. Histopathology 46 (2005) 195-201
19. Makretsov N., et al. Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer. Hum. Pathol. 34 (2003) 1001-1008
20. Bonkhoff H. Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status. Ann. Oncol. 12 (2001) S141-S144
21. Moody T.W., et al. Neuropeptides as autocrine growth factors in cancer cells. Curr. Pharm. Des. 9 (2003) 495-509
22. Mariot P., et al. Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells. J. Biol. Chem. 277 (2002) 10824-10833
23. Gackière F., et al. Cav3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells. J. Biol. Chem. 283 (2008) 10162-10173
24. Voets T., et al. TRPM8. Handb. Exp. Pharmacol. 179 (2007) 329-344
25. Tsavaler L., et al. Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Res. 61 (2001) 3760-3769
26. Bidaux G., et al. Evidence for specific TRPM8 expression in human prostate secretory epithelial cells: functional androgen receptor requirement. Endocr. Relat. Cancer 12 (2005) 367-382
27. Bidaux G., et al. Prostate cell differentiation status determines transient receptor potential melastatin member 8 channel subcellular localization and function. J. Clin. Invest. 117 (2007) 1647-1657
28. Rohács T., et al. PI(4,5)P2 regulates the activation and desensitization of TRPM8 channels through the TRP domain. Nat. Neurosci. 8 (2005) 626-634
29. 2+-independent phospholipase A2-dependent gating of TRPM8 by lysophospholipids. J. Biol. Chem. 281 (2006) 40174-40182
30. Andersson D.A., et al. Modulation of the cold-activated channel TRPM8 by lysophospholipids and polyunsaturated fatty acids. J. Neurosci. 27 (2007) 3347-3355
31. Jull B.A., et al. Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells. J. Cancer Res. Clin. Oncol. 127 (2001) 707-717
32. 2+ channel expression in human esophageal carcinomas: A functional role in proliferation. Cell Calcium 43 (2008) 49-58
33. Marino A.A., et al. Association between cell membrane potential and breast cancer. Tumour Biol. 15 (1994) 82-89
34. 2+. Life Sci. 82 (2008) 764-771
35. Li Y., et al. FSH stimulates ovarian cancer cell growth by action on growth factor variant receptor. Mol. Cell Endocrinol. 267 (2007) 26-37
36. Bödding M. TRP proteins and cancer. Cell Signal. 19 (2007) 617-624
37. Zhuang L., et al. Calcium-selective ion channel, CaT1, is apically localized in gastrointestinal tract epithelia and is aberrantly expressed in human malignancies. Lab. Invest. 82 (2002) 1755-1764
38. 2+ channel expression. Biochem. Biophys. Res. Commun. 322 (2004) 1359-1363
39. Bolanz K.A., et al. The role of TRPV6 in breast carcinogenesis. Mol. Cancer Ther. 7 (2008) 271-279
40. 2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression. Oncogene 22 (2003) 7858-7861
41. 2+/NFAT-dependent pathways. Oncogene 26 (2007) 7380-7385
42. 2+ entry and proliferation of prostate cancer epithelial cells. Cancer Res. 66 (2006) 2038-2047
43. Bouillon R., et al. Intestinal calcium absorption: molecular vitamin D mediated mechanisms. J. Cell Biochem. 88 (2003) 332-339
44. Duncan L.M., et al. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res. 58 (1998) 1515-1520
45. Guilbert A., et al. Evidence that TRPM7 is required for breast cancer cell proliferation. Am. J. Physiol. Cell Physiol. 297 (2009) C493-C502
46. Ikuma M., et al. Role of apical H-K exchange and basolateral K channel in the regulation of intracellular pH in rat distal colon crypt cells. J. Membr. Biol. 166 (1998) 205-212
47. Wonderlin W.F., and Strobl J.S. Potassium channels, proliferation and G1 progression. J. Membr. Biol. 154 2 (1996) 91-107
48. + current that regulates progression through early G1 phase of the cell cycle in MCF-7 human breast cancer cells. J. Membr. Biol. 171 (1999) 35-46
49. + channels in breast cancer cells: association with cell cycle progression. Am. J. Physiol. Cell Physiol. (2004) C125-C134
50. + channels in MIN-6 cells. J. Physiol. 532 Pt 1 (2001) 127-142
51. Stringer B.K., et al. Overexpression of the G-protein inwardly rectifying potassium channel 1 (GIRK1) in primary breast carcinomas correlates with axillary lymph node metastasis. Cancer Res. 61 (2001) 582-588
52. Plummer III H.K., et al. Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines. BMC Cancer 5 (2005) 104
53. Plummer III H.K., et al. Expression of inwardly rectifying potassium channels (GIRKs) and beta-adrenergic regulation of breast cancer cell lines. BMC Cancer 4 (2004) 93
54. Schuller H.M. Neurotransmitter receptor-mediated signaling pathways as modulators of carcinogenesis. Prog. Exp. Tumor Res. 39 (2007) 45-63
55. Mu D., et al. Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell 3 (2003) 297-302
56. Voloshyna I., et al. TREK-1 is a novel molecular target in prostate cancer. Cancer Res. 68 (2008) 1197-1203
57. + channels. EMBO J. 18 (1999) 5540-5547
58. Hemmerlein B., et al. Overexpression of Eag1 potassium channels in clinical tumours. Mol. Cancer. 5 (2006) 41
59. + channels support proliferation of colonic carcinoma cells. FASEB J. 21 (2007) 35-44
60. Pardo L.A., and Stühmer W. Eag1: an emerging oncological target. Cencer Res. 68 (2008) 1611-1613
61. + channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation. J. Cell Physiol. 212 (2007) 690-701
62. Hoffmann E.K., et al. Physiology of cell volume regulation in vertebrates. Physiol. Rev. 89 (2009) 193-277
63. Rouzaire-Dubois B., et al. Cell size-proliferation relationship in rat glioma cells. Glia 45 (2004) 249-257
64. van Horssen R., et al. TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist 11 (2006) 397-408
65. Pardali K., and Moustakas A. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim. Biophys. Acta 1775 (2007) 21-62
66. Vanoverberghe K., et al. Mechanisms of ATP-induced calcium signaling and growth arrest in human prostate cancer cells. Cell Calcium 34 (2003) 75-85
67. Maaser K., et al. Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y(2)-receptors. Br. J. Cancer 86 (2002) 636-844
68. Höpfner M., et al. Growth inhibition and apoptosis induced by P2Y2 receptors in human colorectal carcinoma cells: involvement of intracellular calcium and cyclic adenosine monophosphate. Int. J. Colorectal Dis. 16 (2001) 154-166
69. Schultze-Mosgau A., et al. Characterization of calcium-mobilizing, purinergic P2Y(2) receptors in human ovarian cancer cells. Mol. Hum. Reprod. 6 (2000) 435-442
70. Katzur A.C., et al. Expression and responsiveness of P2Y2 receptors in human endometrial cancer cell lines. J. Clin. Endocrinol. Metab. 84 (1999) 4085-4091
71. Shabbir M., et al. Purinergic receptor-mediated effects of ATP in high-grade bladder cancer. BJU Int. 101 (2008) 106-112
72. Humez S., et al. Role of endoplasmic reticulum calcium content in prostate cancer cell growth regulation by IGF and TNFalpha. J. Cell Physiol. 201 (2004) 201-213
73. 2+ influx. Biochem. J. 397 (2006) 77-87
74. 2+-signalling in human thyroid cancer cells. Mol. Cell Endocrinol. 133 (1997) 33-39
75. Dixon C.J., et al. Extracellular nucleotides stimulate proliferation in MCF-7 breast cancer cells via P2-purinoceptors. Br. J. Cancer 75 (1997) 34-39
76. Shabbir M., et al. Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer. BJU Int. 101 (2008) 352-359
77. + channel function. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7803-7807
78. Han X., et al. Heat shock proteins and p53 play a critical role in K+ channel-mediated tumor cell proliferation and apoptosis. Apoptosis 12 (2007) 1837-1846
79. + channel, a regulator of tumor cell apoptosis and proliferation. Cancer Res. 62 (2002) 4843-4848
80. Hengartner M.O. The biochemistry of apoptosis. Nature 407 (2000) 770-776
81. Orrenius S., et al. Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol. 4 (2003) 552-565
82. 2+ transfer in the control of apoptosis. Oncogene 27 (2008) 6407-6418
83. 2+ homeostasis and store-operated channels in prostate cancer cells. Cancer Cell 1 (2002) 169-179
84. 2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells. Cell Death Differ. 11 (2004) 321-330
85. 2+ homeostasis in apoptotic resistance of prostate cancer cells. Biochem. Biophys. Res. Commun. 322 (2004) 1326-1335
86. 2+-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol. Cell 9 (2002) 163-173
87. Chow J., et al. TRPV6 mediates capsaicin-induced apoptosis in gastric cancer cells -mechanisms behind a possible new "hot" cancer treatment. Biochim. Biophys. Acta 1773 (2007) 565-576
88. Feng Y.H., et al. A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization. J. Biol. Chem. 281 (2006) 17228-17237
89. + channels in apoptosis. J. Membr. Biol. 209 (2006) 3-20
90. + channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11 (2007) 37-51
91. Han Y., et al. Detection of potassium currents and regulation of multidrug resistance by potassium channels in human gastric cancer cells. Cell Biol. Int. 31 (2007) 741-747
92. Meuth S.G., et al. The two-pore domain potassium channel TASK3 functionally impacts glioma cell death. J. Neurooncol. 87 (2008) 263-270
93. + channel blocker, in HepG2 human hepatoblastoma cells. Pharmacology 60 (2000) 74-81
94. - current and ClC-3 expression in human prostate cancer epithelial cells. Cancer Res. 64 (2004) 4841-4848
95. Lemonnier L., et al. Alterations in the regulatory volume decrease (RVD) and swelling-activated Cl- current associated with neuroendocrine differentiation of prostate cancer epithelial cells. Endocr. Relat. Cancer 12 (2005) 335-349
96. Cheng G., et al. Involvement of chloride channels in TGF-beta1-induced apoptosis of human bronchial epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 293 (2007) L1339-L1347
97. Weylandt K.H., et al. ClC-3 expression enhances etoposide resistance by increasing acidification of the late endocytic compartment. Mol. Cancer Ther. 6 (2007) 979-986
98. Cheung A.L., and Deng W. Telomere dysfunction, genome instability and cancer. Front. Biosci. 13 (2008) 2075-2090
99. Liao C.H., et al. Nuclear translocation of telomerase reverse transcriptase and calcium signaling in repression of telomerase activity in human lung cancer cells by fungal immunomodulatory protein from Ganoderma tsugae. Biochem. Pharmacol. 74 (2007) 1541-1554
100. Rosenberger S., et al. A novel regulator of telomerase. S100A8 mediates differentiation-dependent and calcium-induced inhibition of telomerase activity in the human epidermal keratinocyte line HaCaT. J. Biol. Chem. 282 (2007) 6126-6135
101. Bickenbach J.R., et al. Telomerase is not an epidermal stem cell marker and is downregulated by calcium. J. Invest. Dermatol. 111 (1998) 1045-1052
102. Alfonso-De Matte M.Y., et al. Calcium-mediated telomerase activity in ovarian epithelial cells. Arch. Biochem. Biophys. 399 (2002) 239-244
103. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29 (2002) 15-18
104. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 69 Suppl 3 (2005) 4-10
105. Ellis L.M., and Hicklin D.J. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat. Rev. Cancer 8 (2008) 579-591
106. Munaron L. Intracellular calcium, endothelial cells and angiogenesis. Recent Pat. Anticancer Drug Discov. 1 (2006) 105-119
107. Faehling M., et al. Essential role of calcium in vascular endothelial growth factor A-induced signaling: mechanism of the antiangiogenic effect of carboxyamidotriazole. FASEB J. 16 (2002) 1805-1807
108. Kohn E.C., et al. Angiogenesis: role of calcium-mediated signal transduction. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 1307-1311
109. Luzzi K.J., et al. Inhibition of angiogenesis in liver metastases by carboxyamidotriazole (CAI). Angiogenesis 2 (1998) 373-379
110. Enfissi A., et al. The blocking of capacitative calcium entry by 2-aminoethyl diphenylborate (2-APB) and carboxyamidotriazole (CAI) inhibits proliferation in Hep G2 and Huh-7 human hepatoma cells. Cell Calcium 36 (2004) 459-467
111. Kwan H.Y., et al. TRP channels in endothelial function and dysfunction. Biochim. Biophys. Acta 1772 (2007) 907-914
112. Cheng H.W., et al. VEGF activates receptor-operated cation channels in human microvascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1768-1776
113. Ge R., et al. Critical role of TRPC6 channels in VEGF-mediated angiogenesis. Cancer Lett. 283 (2009) 43-51
114. + channels in human mesenteric artery: a single-cell reverse transcriptase-polymerase chain reaction and electrophysiological study in situ. Circ. Res. 87 (2000) 496-503
115. Hu J., et al. Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model. Mol. Cancer 6 (2007) 22
116. + channels inhibits proliferation of human endothelial cells induced by basic fibroblast growth factor. J. Vasc. Res. 35 (1998) 363-371
117. + channels in human endothelial cells in culture. Int. J. Biochem. Cell Biol. 33 (2001) 337-346
118. Downie B.R., and at al. Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors. J. Biol. Chem. 283 (2008) 36234-36240
119. Masi A., and at al. hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines. J. Biol. Chem. 283 (2008) 36234-36240
120. Fraser S.P., et al. Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin. Cancer Res. 11 (2005) 5381-5389
121. Diss J.K., et al. A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo. Prostate Cancer Prostatic Dis. 8 (2005) 266-273
122. Diaz D., et al. Functional expression of voltage-gated sodium channels in primary cultures of human cervical cancer. J. Cell Physiol. 210 (2007) 469-478
123. Brackenbury W.J., et al. The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells. Breast Cancer Res. Treat. 101 (2007) 149-160
124. Roger S., et al. Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines. Int. J. Biochem. Cell Biol. 39 (2007) 774-786
125. Monk M., and Holding C. Human embryonic genes re-expressed in cancer cells. Oncogene 20 (2001) 8085-8091
126. + currents in human astrocytoma cell lines. Glia 34 (2001) 59-67
127. + channel activity and Transwell migration in Mat-LyLu rat prostate cancer cell line. J. Cell Physiol. 210 (2007) 602-608
128. Uysal-Onganer P., and Djamgoz M.B. Epidermal growth factor potentiates in vitro metastatic behaviour of human prostate cancer PC-3 M cells: involvement of voltage-gated sodium channel. Mol. Cancer 6 (2007) 76
129. Vila-Carriles W.H., et al. Surface expression of ASIC2 inhibits the amiloride-sensitive current and migration of glioma cells. J. Biol. Chem. 281 (2006) 19220-19232
130. Kapoor N., et al. Knockdown of ASIC1 and epithelial sodium channel subunits inhibits glioblastoma whole cell current and cell migration. J. Biol. Chem. 284 (2009) 24526-24541
131. Potier M., et al. Identification of SK3 channel as a new mediator of breast cancer cell migration. Mol. Cancer Ther. 5 (2006) 2946-2953
132. Schwab A., et al. Subcellular distribution of calcium-sensitive potassium channels (IK1) in migrating cells. J. Cell Physiol. 206 (2006) 86-94
133. Kessler W., et al. Activation of cell migration with fibroblast growth factor-2 requires calcium-sensitive potassium channels. Pflugers Arch. 456 (2008) 813-823
134. Lastraioli E., et al. herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells. Cancer Res. 64 (2004) 606-611
135. Deshane J., et al. Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J. Biol. Chem. 278 (2003) 4135-4144
136. 2+ channels in prostate cancer epithelial cells: function, regulation, and role in carcinogenesis. Cell Calcium 33 (2003) 357-373
137. 2+ modulation of volume-regulated anion channels: evidence for colocalization with store-operated channels. FASEB J. 16 (2002) 222-224
138. Wei C., et al. Calcium flickers steer cell migration. Nature 457 (2009) 901-905
139. Huang J.B., et al. Identification of channels promoting calcium spikes and waves in HT1080 tumor cells: their apparent roles in cell motility and invasion. Cancer Res. 64 (2004) 2482-2489
140. Waning J., et al. A novel function of capsaicin-sensitive TRPV1 channels: involvement in cell migration. Cell Calcium 42 (2007) 17-25
141. CRAC in vascular smooth muscle cells: role in proliferation and migration. FASEB J. 23 (2009) 2425-2437
142. Yang S., et al. Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 15 (2009) 124-134
143. Denmeade S.R., and Isaacs J.T. The SERCA pump as a therapeutic target: making a "smart bomb" for prostate cancer. Cancer Biol. Ther. 4 (2005) 14-22
144. Kroemer G., and Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13 (2008) 472-482
145. Luo J., et al. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136 (2009) 823-837
146. 2+ channels. Annu. Rev. Cell Dev. Biol. 16 (2000) 521-555
147. Collingridge G.L., et al. A nomenclature for ligand-gated ion channels. Neuropharmacology 56 (2009) 2-5
148. Venkatachalam K., and Montell C. TRP channels. Annu. Rev. Biochem. 76 (2007) 387-417
149. Hewavitharana T., et al. Role of STIM and Orai proteins in the store-operated calcium signaling pathway. Cell Calcium 42 (2007) 173-182